ENHANZE® drug delivery technology : advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20 /

ENHANZE® drug delivery technology : advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20 /

'ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20' provides readers with in-depth information on the potential benefits and challenges of subcutaneous (SC) drug delivery, the biology of hyaluronan and hyaluronidases in the S...

Full description

Bibliographic Details
Main Author: Bittner, Beate (Autor/a)
Other Authors: Locke, Kenneth W. (Autor/a), Maneval, Daniel C. (Autor/a), Flamion, Bruno (Autor/a), Connor, Robert J. (Autor/a), Kang, David W. (Editor/a), Tannenbaum, Renee (Editor/a)
Format: Book
Language:English
Published: UK : Karger, 2022.
Subjects:
HIALURONIDASA > USO TERAPÉUTICO > ADMINISTRACIÓN
INYECCIONES HIPODERMICAS
ADMINISTRACIÓN DE DROGAS
Online Access:Ver documento en línea
Description
Summary:'ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20' provides readers with in-depth information on the potential benefits and challenges of subcutaneous (SC) drug delivery, the biology of hyaluronan and hyaluronidases in the SC space, and a comprehensive overview on the history of hyaluronidases and the development of recombinant human hyaluronidase PH20 (rHuPH20). Current applications of rHuPH20 as well as approved biotherapeutics utilizing HuPH20-facilitated SC drug delivery are summarized, and the underlying non-clinical and clinical development approaches are introduced as a basis for future application to biologics in various disease areas.
Physical Description:1 recurso en línea (104 páginas) : ilustraciones a color, archivo de texto, PDF.
ISBN:9783318070873
9783318070767
Access:Acceso al texto completo para la comunidad de la UCR por medio de la cuenta institucional

Similar Items